A European study investigating patient-reported outcomes of CAR T-cell therapy

Ide-cel in R/R myeloma: patient-reported outcomes and resistanceПодробнее

Patient-reported outcomes with CAR T-cell therapyПодробнее

Patient-reported outcomes vs performance-based metrics: the effects of CAR-T therapy on cognitionПодробнее

Patient-reported outcomes in CAR-T recipientsПодробнее

CAR T-cell therapy: the patient's perspectiveПодробнее

Investigating CAR T-cell therapy in the treatment of MSПодробнее

The patient's voice in CAR T-cell regulatory processesПодробнее

EONS14 Car-T Cell therapy and managementПодробнее

The impact of patient education on health outcomes for CAR T-cell therapyПодробнее

Real World Outcomes of CAR T Therapy – Experiences from Different ContinentsПодробнее

Highlights from the 3rd European CAR T-cell MeetingПодробнее

An insight into the myeloma patient perspective on PROs in CAR-T clinical trialsПодробнее

The impact of patient education on health outcomes for CAR T-cell therapyПодробнее

How CAR T-Cell Therapy Is Curing CancerПодробнее

Efficacy of bispecific CD19/CD22 CAR T-cells in B-cell malignanciesПодробнее

WVU Medicine Health Report: CAR T-Cell TherapyПодробнее

CAR T-Cell Therapy Clinical TrialsПодробнее

Patient perspectives of CAR T-cell regulationПодробнее

CAR T-cell therapy access and reimbursement: the patient's perspectiveПодробнее